Spotlight on Afatinib and Its Potential in the Treatment of Squamous Cell Lung Cancer: The Evidence So Far

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s92996
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

New Developments in the Treatment of Advanced Squamous Cell Lung Cancer: Focus on Afatinib

OncoTargets and Therapy
OncologyPharmacology
2017English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Spotlight on Tocilizumab and Its Potential in the Treatment of Systemic Sclerosis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Spotlight on Siponimod and Its Potential in the Treatment of Secondary Progressive Multiple Sclerosis: The Evidence to Date

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Clinical Efficacy and Safety of Afatinib in the Treatment of Non-Small-Cell Lung Cancer in Chinese Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

Algorithm for the Treatment of Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer: An Evidence-Based Overview

Current Oncology
Oncology
2018English

The Story So Far: Cell Biology

Journal of Cell Science
Cell Biology
2002English

P2.11-07 Lung Cancer in a Tertiary Care Setting: So Near, Yet So Far

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Lung Cancer in Europe: Turning the Spotlight on the Biggest Cancer Killer

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy